SIAS

It is the third time that ST senior correspondent Angela Tan has been recognised at the annual Sias Investors’ Choice Awards.

ST journalist wins Financial Story of the Year award

Angela Tan recognised for scoop on Kwek family feud; Lianhe Zaobao, CNA938, The Edge Singapore also bag awards

David Gerald of Sias says that a company’s board sets the tone from the top and is key to fostering the right culture.

Corporate governance and culture must go hand in hand amid complex challenges: Sias

They are ‘two sides of the same coin’, says founder, president and CEO David Gerald

Unequivocal IFA independence would boost confidence in the market, which could lead to more interest and improved liquidity.
THINKING ALOUD

Ensuring IFA independence is crucial

In an ideal world, the independent financial adviser would be appointed by an external party – possibly regulators or even Sias – and should not receive payment from target companies

MAS launched a public consultation on Jul 1 and is seeking feedback until Sep 1.

MAS proposals a step forward in ‘democratising’ investing, ‘strikes right balance’: observers

The move is seen as a response to industry feedback, aiming to reduce complexity and broaden retail investor access to a wider range of financial products

David Gerald, president of Sias, which is advising the minority shareholders of Singapore Paincare to hold off selling their stakes before the report by the independent financial adviser  is released.
HOT STOCK

Singapore Paincare up 12.1% as Sias urges shareholders to await IFA report

The activist for good corporate governance and investor rights says the company could be worth up to S$0.37 a share, more than twice its S$0.16 offer price

David Gerald, founder, president and chief executive of Sias, recommends that shareholders wait for the independent financial adviser report before making any moves.

Sias calls for Singapore Paincare shareholders to await IFA opinion on privatisation offer

It notes that the group could be worth more as ‘well-managed healthcare companies generally trade at premiums to their net asset value’